Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer. [electronic resource]
Producer: 20170705Description: 385-393 p. digitalISSN:- 1521-4141
- Animals
- Antibodies, Monoclonal -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- CTLA-4 Antigen -- immunology
- Cell Line, Tumor
- Cytokines -- metabolism
- Drug Therapy, Combination
- Growth Inhibitors -- therapeutic use
- Immunotherapy -- methods
- Lymphocyte Depletion
- Male
- Mice
- Mice, Inbred C57BL
- Neoplasm Transplantation
- Neoplasms, Experimental
- Programmed Cell Death 1 Receptor -- immunology
- T-Lymphocytes, Regulatory -- immunology
- Urinary Bladder Neoplasms -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.